Inborn errors of metabolism:

Indications for: KANUMA

Treatment of lysosomal acid lipase (LAL) deficiency.

Adults and Children:

<1 month: not established. Give as IV infusion over ≥2hrs; consider further prolonging infusion time for the 3mg/kg dose or if a hypersensitivity reaction occurs. May consider a 1hr infusion for the 1mg/kg dose in those who tolerate the infusion. ≥1 month: 1mg/kg once every other week. If rapidly progressive within first 6 months of life: initially 1mg/kg once weekly; increase to 3mg/kg once weekly if optimal response not achieved. May pre-treat with antipyretics and/or antihistamines.

KANUMA Warnings/Precautions:

Monitor for hypersensitivity reactions during and after infusion; interrupt or lower infusion rate based on severity. Discontinue immediately and treat if severe hypersensitivity including anaphylaxis occurs. Eggs or egg products allergy. Pregnancy. Nursing mothers.

KANUMA Classification:

Hydrolytic lysosomal cholesteryl ester and triacylglycerol-specific enzyme.

Adverse Reactions:

Diarrhea, vomiting, fever, rhinitis, anemia, cough, nasopharyngitis, urticaria, headache, oropharyngeal pain, asthenia, constipation, nausea.

Generic Drug Availability:


How Supplied:

Single-use vials—1